Ian S. Hagemann
Ian S. Hagemann
Associate Professor, Dept. of Pathology and Immunology, Washington University in St. Louis
Verified email at
Cited by
Cited by
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ...
Nature 475 (7355), 226-230, 2011
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
GT Motz, SP Santoro, LP Wang, T Garrabrant, RR Lastra, IS Hagemann, ...
Nature medicine 20 (6), 607-615, 2014
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis
WT Hwang, SF Adams, E Tahirovic, IS Hagemann, G Coukos
Gynecologic oncology 124 (2), 192-198, 2012
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor
E Lanitis, M Poussin, IS Hagemann, G Coukos, R Sandaltzopoulos, ...
Molecular Therapy 20 (3), 633-643, 2012
Clinical next‐generation sequencing in patients with non–small cell lung cancer
IS Hagemann, S Devarakonda, CM Lockwood, DH Spencer, K Guebert, ...
Cancer 121 (4), 631-639, 2015
Validation of a next-generation sequencing assay for clinical molecular oncology
CE Cottrell, H Al-Kateb, AJ Bredemeyer, EJ Duncavage, DH Spencer, ...
The Journal of molecular diagnostics 16 (1), 89-105, 2014
High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models
JP Monaco, JE Tomaszewski, MD Feldman, I Hagemann, M Moradi, ...
Medical image analysis 14 (4), 617-629, 2010
Geometric Magnetic Frustration in Ba2Sn2Ga3ZnCr7O22: A Two-Dimensional Spinel Based Kagomé Lattice
IS Hagemann, Q Huang, XPA Gao, AP Ramirez, RJ Cava
Physical review letters 86 (5), 894-897, 2001
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialPembrolizumab in …
R Uppaluri, KM Campbell, AM Egloff, P Zolkind, ZL Skidmore, ...
Clinical Cancer Research 26 (19), 5140-5152, 2020
Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).
R Uppaluri, P Zolkind, T Lin, B Nussenbaum, RS Jackson, J Rich, ...
Journal of Clinical Oncology 35 (15_suppl), 6012-6012, 2017
Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels
E Lanitis, D Dangaj, IS Hagemann, DG Song, A Best, R Sandaltzopoulos, ...
Plos one 7 (11), e49829, 2012
Risk of occult malignancy in morcellated hysterectomy: a case series
IS Hagemann, AR Hagemann, VA LiVolsi, KT Montone, CS Chu
International journal of gynecological pathology 30 (5), 476-483, 2011
T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides
KE Sufficool, CM Lockwood, HJ Abel, IS Hagemann, JA Schumacher, ...
Journal of the American Academy of Dermatology 73 (2), 228-236. e2, 2015
Synthesis, structure and physical properties of Ru ferrites: BaMRu5O11 (M= Li and Cu) and BaM′2Ru4O11 (M′= Mn, Fe and Co)
ML Foo, Q Huang, JW Lynn, WL Lee, T Klimczuk, IS Hagemann, NP Ong, ...
Journal of Solid State Chemistry 179 (2), 563-572, 2006
A phase II trial of neoadjuvant MK-2206, an AKT inhibitor, with anastrozole in clinical stage II or III PIK3CA-mutant ER-positive and HER2-negative breast cancerneoadjuvant MK …
CX Ma, V Suman, MP Goetz, D Northfelt, ME Burkard, F Ademuyiwa, ...
Clinical Cancer Research 23 (22), 6823-6832, 2017
Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor ImmunityBreast Cancer Neoantigens Can Induce Antitumor Immunity
X Zhang, S Kim, J Hundal, JM Herndon, S Li, AA Petti, SD Soysal, L Li, ...
Cancer immunology research 5 (7), 516-523, 2017
Evaluation of ovarian cancer: initial application of coregistered photoacoustic tomography and US
S Nandy, A Mostafa, IS Hagemann, MA Powell, E Amidi, K Robinson, ...
Radiology 289 (3), 740-747, 2018
Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers
B Zhang, XY Xing, J Li, RF Lowdon, Y Zhou, N Lin, B Zhang, V Sundaram, ...
BMC genomics 15, 1-21, 2014
The ovarian cancer chemokine landscape is conducive to homing of vaccine-primed and CD3/CD28–costimulated T cells prepared for adoptive therapy
E Zsiros, P Duttagupta, D Dangaj, H Li, R Frank, T Garrabrant, ...
Clinical Cancer Research 21 (12), 2840-2850, 2015
Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy
IS Hagemann, CE Cottrell, CM Lockwood
Cancer genetics 206 (12), 420-431, 2013
The system can't perform the operation now. Try again later.
Articles 1–20